Autolus Therapeutics

AI Score

0

Unlock

1.74
0.01 (0.58%)
At close: Mar 03, 2025, 3:59 PM
1.75
0.86%
After-hours: Mar 03, 2025, 04:00 PM EST

Autolus Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -208.38M -148.84M -142.1M -142.09M -123.85M -31.11M -19.73M -12.55M -7.46M
Depreciation & Amortization 6.57M 7.42M 8.46M 5.66M 4.61M 1.1M 1.01M 478K 3.64M
Stock-Based Compensation 11.2M 12.01M 9.94M 20.11M 30.21M 5.03M 3.15M 2.26M n/a
Other Working Capital 801K 3.95M 5.95M -29K -14.75M -3.23M -1.23M -1.74M n/a
Other Non-Cash Items 45.72M 13.39M 1.77M -1.5M 4.14M -1.07M 5.17M 1.2M 916.23K
Deferred Income Tax -986K -268K -72K -1.34M -399K -5.21M n/a n/a n/a
Change in Working Capital 292K 3.97M 4.14M 1.41M -16.2M 5.42M -795K -1.23M -413.95K
Operating Cash Flow -145.59M -112.31M -117.86M -117.76M -101.48M -25.85M -16.36M -9.85M -3.33M
Capital Expenditures -10.99M -10.84M -8.86M -14.68M -18.67M -8.77M -2.88M -1.85M -762.07K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a -327K 1.13M n/a n/a 7.92K
Investing Cash Flow -10.99M -10.84M -8.86M -14.68M -18.67M -7.65M -2.88M -1.85M -754.14K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a -3.18M n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -883K 59.76M 38.16M -5.33M -7.06M 156.92M 127.69M 32.22M 12.23M
Financial Cash Flow -883K 223.61M 284.06M 74.42M 108.86M 117.49M 127.69M 32.22M 12.23M
Net Cash Flow -142.43M 72.08M 156.59M -57.34M -6.13M 86.98M 109.01M 17.86M 8.15M
Free Cash Flow -156.57M -123.15M -126.72M -132.44M -120.15M -34.62M -19.24M -11.7M -4.09M